GLAND PHARMA IPO Listing Price, Date & Time (Listing Day Kya Kre?)

GLAND PHARMA Ltd IPO Review (Gland Pharma IPO), Dates, Price Bands, Market Lot, Gland Pharma IPO Grey Market Price, Listing Date & Time Details

Let’s have a detailed review of the company and analytics of the Gland Pharma Limited IPO release date, IPO offer price, subscription, Gland Pharma IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.

Gland Pharma Limited launch IPO in November, to raise Rs 6500 crore. The initial public offer (IPO) of Gland pharma limited is expected to be launched on November 2020.

Hyderabad-based Gland Pharma is set to launch its maiden initial public offer on November 9 to raise about Rs 6,500 crore. The price band for the offer has been fixed at Rs 1,490-1,500 per share. The issue will close on 11 November.

Gland Pharma gets Sebi approval for Rs 6,500-crore IPO, set for first listing of an Indian firm with a Chinese parent. The IPO is a mixture of primary and secondary issue of shares with both China’s Fosun group and the founders of Gland Pharma due to dilute shares. Gland Pharma launch the IPO in November 2020.

Source:- https://www.moneycontrol.com/news/business/ipo/gland-pharma-gets-sebi-approval-for-rs-6000-crore-ipo-set-for-first-listing-of-an-indian-firm-with-a-chinese-parent-5995831.html

About Gland Pharma

Gland Pharma one of the fastest-growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). They are present in sterile injectables, oncology, and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products, and 505(b)(2) filings.

Gland Pharma is typically a B2B company. Generic injectable are bio-equivalent of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredients, dosage, strength, quality, form, etc.

A series of IPOs have been launched in recent months. but no pharma company has listed on the Indian bourses this year. The last IPO by an Indian drug maker—Eris Lifesciences— was more than three years ago in June 2017. The offer is likely to comprise a fresh issue aggregating up to Rs 1,250 crore and an offer for sale of up to Rs 4,750 crore.

Gland Pharma IPO – Issue Details:

Issuer Gland Pharma Ltd.
Issue Type Book Built Issue IPO
Issue Period Issue Opens: November 9, 2020
Issue Closes: November 11, 2020
Price Brand ₹ 1490 – 1500 (Tentative) Equity share
Issue Size ₹6500 Crores (Approx.)
Face Value Rs.1 per Equity Share
Market Lot 10 Shares and in multiples thereof
Maximum Bid amount for Retail Rs. 2 Lakhs
QIB 50% of the issue size
NIB 15% of the issue size
Retail Individual Bidders 35% of the issue size
Offer for Sale 34,863,635 shares
(INR5,194.68 – 5,229.55 crore)
Fresh Issue ₹1250 Cr (Expected)
Listing at NSE & BSE
Apply With Upstox Free DEMAT Account
Book Running Lead Managers  
Grey Market Price Gland Pharma IPO GMP Today

Gland Pharma IPO Listing

Gland Pharma IPO Review

List of Upcoming IPO in India (NEXT BIG IPOs)

UPCOMING IPO IN NOVEMBER 2020

Gland Pharma IPO GMP Today

Top 5 Multibagger Stocks to buy today

Gland Pharma IPO Dates & Price Band

 IPO Open: November 9, 2020
 IPO Close: November 11, 2020
 IPO Size: Approx ₹6500 Crores
 Face Value:  ₹1 Per Equity Share
 Price Band: ₹ 1490 – ₹1500 Per Share
 Listing on:  BSE & NSE
 Retail Portion:  35%
Total IPO size 34,863,635 Shares

Gland Pharma IPO Market Lot:

 Lot Size: Minimum – 10 Shares & Maximum – 130 Shares
 Minimum Amount: ₹15000
 Maximum Amount: ₹195,000

Gland Pharma IPO Allotment & Listing Dates:

 Basis of Allotment: November 17, 2020
 Refunds: November 18, 2020
 Credit to Demat Account: November 19, 2020
 Listing Date: November 20, 2020

Objects of the Issue: The bank proposes to utilize the Net Proceeds from the fresh issue offer towards augmenting the Bank’s Tier I capital base to meet the future capital requirement.

Gland Pharma IPO – Promoters

The Promoter of this company is:

  • FOSUN PHARMA INDUSTRIAL PTE. LTD
  • SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Gland Pharma Financial

On the basis of Standalone statement:

Financials of Gland Pharma IPO:

Particulars (Cr) FY18 FY19 FY20
Revenue 1622 2044 2633
EBITDA 584 792 1094
PAT 321 451 772

Revenue Contributions Country-wise

Countries FY18 FY19 FY20
USA 71.25% 62.50% 66.74%
India 18.49% 18.97% 17.74%
Europe 3.39% 5.38% 4.44%
Canada 1.08% 1.12% 1.78%
Australia 0.69% 0.44% 0.50%
Rest of the world 5.10% 11.59% 8.80%

Gland Pharma IPO  [Download DRHP Prospectus]

How to Apply for Gland Pharma IPO?

If you have a Demat account, most banks offer the online IPO application. You can also contact the broker to apply for in MDL ltd IPO? Most banks including the SBI bank, ICICI Bank, Axis, and Kotak bank allow the customer to apply in IPO using the Demat account.

How to Check Gland Pharma IPO Allotment?

Check Gland Pharma IPO Allotment Here: OR Log on to https://www.linkintime.co.in/IPO/public-issues.html

Note: Gland Pharma IPO Allotment Status will be available whenever the Registrar of IPO will put on their official sites.

 # Option 1: BSE Website:

  • Go to BSE Website
  • Check box “Equity”
  • Select IPO Name Gland Pharma
  • Type Your Application Number
  • Type Your Pan Number

# Option 2: LINKintine Website:

  • Go to LINKintime Website
  • Select IPO Name Gland Pharma
  • Select Option from PAN Number, Application Number or Demat Account Number
  • As per selection add  PAN Number, Application Number or Demat Account Number

# Option 3: in Your Demat Account:

  • Call Your Broker or Login to Your Demat Account / Trading Account
  • Check the stock is credited to your account or not

# Option 4:  in Your Bank Account:

  • Login to your Bank Account
  • Check the Amount is debited or released

Gland Pharma IPO Listing Gain

How to Sell Gland Pharma IPO Shares on Listing Day?

Gland Pharma IPO Listing Day Kya kre?

Gland Pharma IPO Lead Managers

Lead Managers
  • Kotak Mahindra Capital Company Limited
  • Citigroup Global Markets India Private Limited
  • Haitong Securities India Private Limited
  • Nomura Financial Advisory and Securities (India) Private Limited

Gland Pharma IPO Registrar to Offer

Gland Pharma IPO Registrar
Link Intime India Private Limited
C-101, 1st Floor
247 Park Lal Bahadur Shastri Marg
Vikhroli (West) Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: glandpharma.ipo@linkintime.co.in
Investor grievance e-mail:
glandpharma.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058

Other Details:

  • Statutory Auditor – S.R. Batliboi & Associates LLP
  • Legal Counsel to the Company – Cyril Amarchand Mangaldas
  • Bankers to the Company – HDFC Bank Limited, State Bank of India, Canara Bank (e-Syndicate Bank), The Hongkong and Shanghai Banking Corporation Limited and Standard Chartered Bank.
Company Contact Info:

Registered Office

Gland Pharma Limited
Survey No. 143-148, 150 & 151
Near Gandimaisamma ‘X’ Roads
D.P. Pally, Dundigal Gandimaisamma Mandal
Medchal-Malkajgiri District
Hyderabad 500043, Telangana, India

 Phone: +91-40-30510999
 Fax: +91-40-30510800
 Email: gland@glandpharma.com

What is IPO? आईपीओ क्या हैं? आईपीओ का फुल फॉर्म क्या है?
Gland Pharma IPO Allotment status

Link Intime Website (Click on the below Link)

https://linkintime.co.in/MIPO/IPO_App.aspx

Final Words

Dear readers, I hope that the above information about “Gland Pharma IPO” has been of great use. If you find the above information useful please share it with others via Facebook and Twitter. You can check more investment researched videos on our YouTube Channel.

SUBSCRIBE YOUTUBE CHANNEL JOIN TELEGRAM CHANNEL for LATEST UPDATES

It is important to be financially literate to make a well-informed investment decision. Stay tuned for more updates. Like, share and subscribe. Drop your comment, queries or feedback in the given below comment box. We would love to hear from you. Thanks and have a nice day.

Gland Pharma IPO FAQs

When Gland Pharma IPO will open?

The Gland Pharma IPO will open in November 9, 2020

When Gland Pharma IPO will open for Anchor Investors?

The Anchor Investors bidding date is November 8, 2020.

What is Gland Pharma IPO Investors Portion?

The investors’ portion for QIB-50%, NII-15%, and Retail-35%.

What is the Gland Pharma IPO Size?

The IPO Size is 6500 Crore with Offer for Sale of 5,229 crores and fresh issue 1250 cr.

What is the lot size of Gland Pharmaceuticals IPO?

Gland Pharma IPO lot size is 10 Shares and the minimum order quantity is 10 Shares.

What is price band of Gland Pharma IPO?

Gland Pharma IPO lot size is ₹ 1490 – 1500 (Tentative) Equity share and the minimum order quantity is 10 Shares.

What is Gland Pharma IPO Allotment Date?

Gland Pharma IPO allotment date is November 17, 2020. You can check IPO allotment status here.

What is Gland Pharma IPO Listing Date?

Gland Pharma IPO listing date:- The tentative date of Gland Pharma IPO listing is Nov 20, 2020. The IPO to list on NSE and BSE.

How to Apply Gland Pharma IPO?

You can apply Gland Pharma IPO via ASBA online via your bank account. You can apply ASBA online via UPI through your stock brokers. How to apply IPO through ASBA?
Steps to apply in Gland Pharma IPO through Zerodha
Visit the Zerodha website and login to Console.
Go to Portfolio and click the IPOs link.
Go to the ‘Gland Pharma IPO’ row and click the ‘Bid’ button.
Enter your UPI ID, Quantity, and Price.
‘Submit’ IPO application form.
Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Zerodha IPO Application Process for more detail.

What is the Grey Market Premium (GMP) price of Gland Pharma Limited IPO?

The Grey Market Premium (GMP) price of Gland Pharma IPO is approx. in between Rs.1500 – 2000/- at the moment.

What is the Subject to Sauda price for Gland Pharma IPO?

The Subject to Sauda price for Gland Pharma IPO is approx. Rs. 1000/-

LEAVE A REPLY

Please enter your comment!
Please enter your name here